Changes in bone mineral density, 25-hydroxyvitamin D3 and inflammatory factors in patients with hyperthyroidism

被引:3
作者
Zhou, Yali [1 ]
Wang, Xixia [2 ]
Xin, Maoyuan [1 ]
Zhuang, Haiting [3 ]
机构
[1] Weifang Peoples Hosp, Dept Traumat Orthopaed, Weifang 261000, Shandong, Peoples R China
[2] Zhucheng BaiChiHe Hosp, Dept Internal Med, Zhucheng 262217, Shandong, Peoples R China
[3] Weifang Peoples Hosp, Dept Anesthesiol, 151 Guangwen St, Weifang 261000, Shandong, Peoples R China
关键词
hyperthyroidism; bone mineral density; inflammation; vitamin D;
D O I
10.3892/etm.2021.10049
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study aimed to evaluate changes in bone mineral density, 25-hydroxyvitamin D-3 [25-(OH)D-3] and inflammatory factors in patients with hyperthyroidism, in order to determine the correlations with the pathogenesis of hyperthyroidism. A total of 55 patients with hyperthyroidism (observation group) and 53 healthy patients (control group) enrolled at Weifang People's Hospital from March 2017 to February 2018 were randomly enrolled. The thyroid function, bone mineral density, 25-(OH)D-3 and inflammatory factors were measured and compared between the two groups. The measurement data are presented as mean +/- standard deviation (SD), and Student t-test was performed for the comparison between two groups. Chi-square test was used for enumeration data regarding sex. Pearson correlation analysis was performed for two-variable analysis on L1, 25-(OH)D-3, interleukin (IL)-2, IL-6 with FT3, respectively. In regards to the results, no difference in sex, age and body mass index (BMI) between the two groups were found but the thyroid function was markedly enhanced in the observation group compared to the control group. Bone mineral density index and 25-(OH)D-3 in the observation group were significantly lower than those in the control group (P<0.05). There were significant differences in the inflammatory factors between the two groups (P<0.05). The L1, 25-(OH)D-3 and IL-2 levels were significantly negatively correlated with thyroid function index and free triiodothyronine (FT3) while a statistically positive correlation was found between IL-6 and FT3 (P<0.05). In conclusion, abnormal levels of bone mineral density, 25-(OH)D-3 and inflammatory factors are observed in patients with hyperthyroidism, and there are correlations between L1, 25-(OH)D-3, IL-2, IL-6 and FT3 in the pathogenesis of hyperthyroidism, which provides new insight for the diagnosis of hyperthyroidism.
引用
收藏
页数:5
相关论文
共 34 条
  • [1] Ahn HY, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007700, 10.1097/md.0000000000007700]
  • [2] Bone remodelling markers and serum cytokines in patients with hyperthyroidism
    Akalin, A
    Colak, Ö
    Alatas, Ö
    Efe, B
    [J]. CLINICAL ENDOCRINOLOGY, 2002, 57 (01) : 125 - 129
  • [3] Alemu A, 2016, INT J REPROD BIOMED, V14, P677
  • [4] Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
    Bassett, J. H. Duncan
    Williams, Graham R.
    [J]. ENDOCRINE REVIEWS, 2016, 37 (02) : 135 - 187
  • [5] Dual-Energy X-Ray Absorptiometry: Beyond Bone Mineral Density Determination
    Choi, Yong Jun
    [J]. ENDOCRINOLOGY AND METABOLISM, 2016, 31 (01) : 25 - 30
  • [6] Hyperthyroidism
    De Leo, Simone
    Lee, Sun Y.
    Braverman, Lewis E.
    [J]. LANCET, 2016, 388 (10047) : 906 - 918
  • [7] Disorders of Bone Remodeling
    Feng, Xu
    McDonald, Jay M.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6, 2011, 6 : 121 - 145
  • [8] Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
    Golia, Enrica
    Limongelli, Giuseppe
    Natale, Francesco
    Fimiani, Fabio
    Maddaloni, Valeria
    Pariggiano, Ivana
    Bianchi, Renatomaria
    Crisci, Mario
    D'Acierno, Ludovica
    Giordano, Roberto
    Di Palma, Gaetano
    Conte, Marianna
    Golino, Paolo
    Russo, Maria Giovanna
    Calabro, Raffaele
    Calabro, Paolo
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (09)
  • [9] Hp: an inflammatory indicator in cardiovascular disease
    Graves, Karen L.
    Vigerust, David J.
    [J]. FUTURE CARDIOLOGY, 2016, 12 (04) : 471 - 481
  • [10] Gunatilake SSC, 2017, CASE REP ENDOCRINOL, V2017, DOI 10.1155/2017/4050458